Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- Latest filing
- Aug 14, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 76
- +1 vs. Q1 2023
- Portfolio value
- $466.6M
- +$4.66M (+1.0%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| SNYSanofi | SPONSORED ADR | 529,515 | $28.5M | 6.1% | 00.0% | Unchanged | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 285,060 | $20.4M | 4.4% | 00.0% | Unchanged | History |
| JNJJohnson & Johnson | Stock | 119,831 | $19.8M | 4.3% | 00.0% | Unchanged | History |
| NICENICE Ltd. | SPONSORED ADR | 87,482 | $18.1M | 3.9% | −28,000−24.2% | Reduced | History |
| AMZNAmazon Com Inc | Stock | 124,300 | $16.2M | 3.5% | +38,620+45.1% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 723,061 | $15.1M | 3.2% | +40,000+5.9% | Added | History |
| MRKMerck & Co., Inc. | Stock | 120,600 | $13.9M | 3.0% | 00.0% | Unchanged | History |
| Enphase Energy, Inc.29355AAK3 | NOTE 3/0 | 14,310,000 | $13.4M | 2.9% | +3,585,000+33.4% | Added | – |
| MSFTMicrosoft Corp | Stock | 34,312 | $11.7M | 2.5% | −20,311−37.2% | Reduced | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 8,764,334 | $10.1M | 2.2% | +8,764,334 | New | History |
| NVONovo Nordisk A S | ADR | 56,540 | $9.15M | 2.0% | −15,000−21.0% | Reduced | History |
| PNTPOINT Biopharma Global Inc. | COM | 952,642 | $8.63M | 1.8% | 00.0% | Unchanged | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 183,696 | $8.47M | 1.8% | 00.0% | Unchanged | History |
| NVMINova Ltd. | COM | 70,000 | $8.21M | 1.8% | +70,000 | New | History |
| SWTXSpringWorks Therapeutics, Inc. | COM | 312,625 | $8.20M | 1.8% | −5,000−1.6% | Reduced | History |
| SHL Telemedicine Ltd78423T200 | ADS | 714,573 | $7.96M | 1.7% | +714,573 | New | – |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,050,000 | $7.91M | 1.7% | −989,500−48.5% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 40,000 | $7.60M | 1.6% | +40,000 | New | History |
| IRONDisc Medicine, Inc. | COM | 170,578 | $7.57M | 1.6% | −49,435−22.5% | Reduced | History |
| ABBVAbbVie Inc. | Stock | 56,000 | $7.54M | 1.6% | −7,000−11.1% | Reduced | History |
| LLYEli Lilly & Co | Stock | 15,690 | $7.36M | 1.6% | −16,000−50.5% | Reduced | History |
| MRUSMerus N.V. | COM | 278,333 | $7.33M | 1.6% | −58,660−17.4% | Reduced | History |
| IMTXImmatics N.V. | SHS | 617,173 | $7.12M | 1.5% | −163,679−21.0% | Reduced | History |
| MLYSMineralys Therapeutics, Inc. | COM | 405,400 | $6.91M | 1.5% | +66,400+19.6% | Added | History |
| PANWPalo Alto Networks Inc | Stock | 27,000 | $6.90M | 1.5% | +7,000+35.0% | Added | History |
| BIIBBiogen Inc. | COM | 23,846 | $6.79M | 1.5% | −9,670−28.9% | Reduced | History |
| CAMTCamtek Ltd | ORD | 189,494 | $6.75M | 1.4% | −50,000−20.9% | Reduced | History |
| KURAKura Oncology, Inc. | COM | 603,287 | $6.38M | 1.4% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 530,000 | $6.33M | 1.4% | +530,000 | New | History |
| INZYInozyme Pharma, Inc. | COM | 1,131,967 | $6.31M | 1.4% | −649,891−36.5% | Reduced | History |
| TSEMTower Semiconductor Ltd | SHS NEW | 167,446 | $6.28M | 1.3% | +167,446 | New | History |
| FUSNFusion Pharmaceuticals Inc. | COM | 1,329,258 | $6.21M | 1.3% | +45,721+3.6% | Added | History |
| NVSNovartis AG | ADR | 60,000 | $6.05M | 1.3% | 00.0% | Unchanged | History |
| SAGESage Therapeutics, Inc. | COM | 128,000 | $6.02M | 1.3% | −27,000−17.4% | Reduced | History |
| JSPRJasper Therapeutics, Inc. | COM | 4,274,008 | $5.86M | 1.3% | +230,000+5.7% | Added | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 25,000 | $5.78M | 1.2% | +6,000+31.6% | Added | History |
| SRPTSarepta Therapeutics, Inc. | COM | 50,000 | $5.73M | 1.2% | +6,000+13.6% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 321,635 | $5.53M | 1.2% | −240,348−42.8% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 160,000 | $5.43M | 1.2% | +160,000 | New | History |
| ISEEIVERIC bio, Inc. | COM | 134,414 | $5.29M | 1.1% | −97,177−42.0% | Reduced | History |
| MORFMorphic Holding, Inc. | COM | 90,000 | $5.16M | 1.1% | +90,000 | New | History |
| PFEPfizer Inc | Stock | 140,000 | $5.14M | 1.1% | 00.0% | Unchanged | History |
| COGTCogent Biosciences, Inc. | COM | 420,000 | $4.97M | 1.1% | +120,000+40.0% | Added | History |
| KZRKezar Life Sciences, Inc. | COM | 1,988,228 | $4.87M | 1.0% | +100,000+5.3% | Added | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 236,000 | $4.69M | 1.0% | 00.0% | Unchanged | History |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 1,228,665 | $4.68M | 1.0% | −1,131,915−48.0% | Reduced | – |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 50,000 | $4.16M | 0.9% | +50,000 | New | – |
| PTCTPTC Therapeutics, Inc. | COM | 100,100 | $4.07M | 0.9% | −59,000−37.1% | Reduced | History |
| ATXSAstria Therapeutics, Inc. | COM | 471,018 | $3.92M | 0.8% | +50,000+11.9% | Added | History |
| QCOMQualcomm Inc | Stock | 32,000 | $3.81M | 0.8% | +32,000 | New | History |
| ENLTEnlight Renewable Energy Ltd. | SHS | 211,586 | $3.76M | 0.8% | −239,278−53.1% | Reduced | History |
| GSKGSK plc | ADR | 100,000 | $3.56M | 0.8% | +100,000 | New | History |
| TVTXTravere Therapeutics, Inc. | COM | 213,462 | $3.28M | 0.7% | +25,962+13.8% | Added | History |
| GILDGilead Sciences, Inc. | Stock | 40,000 | $3.08M | 0.7% | +40,000 | New | History |
| ETNB89bio, Inc. | COM | 135,000 | $2.56M | 0.5% | +135,000 | New | History |
| ACLXArcellx, Inc. | COMMON STOCK | 77,488 | $2.45M | 0.5% | −90,000−53.7% | Reduced | History |
| RZLTRezolute, Inc. | COM NEW | 1,155,897 | $2.29M | 0.5% | 00.0% | Unchanged | History |
| RNACCartesian Therapeutics, Inc. | COM | 2,038,500 | $2.28M | 0.5% | −286,500−12.3% | Reduced | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 100,000 | $2.16M | 0.5% | +100,000 | New | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 200,000 | $2.06M | 0.4% | 00.0% | Unchanged | History |
| HOWLWerewolf Therapeutics, Inc. | COM | 626,810 | $1.91M | 0.4% | 00.0% | Unchanged | History |
| ALTAltimmune, Inc. | COM NEW | 500,000 | $1.76M | 0.4% | +200,000+66.7% | Added | History |
| QUREuniQure N.V. | SHS | 148,734 | $1.70M | 0.4% | +86,734+139.9% | Added | History |
| VERAVera Therapeutics, Inc. | CL A | 105,000 | $1.69M | 0.4% | +105,000 | New | History |
| RIGLRigel Pharmaceuticals Inc | COM NEW | 1,228,126 | $1.58M | 0.3% | −650,719−34.6% | Reduced | History |
| CGENCompugen Ltd | ORD | 1,229,808 | $1.40M | 0.3% | +1,229,808 | New | History |
| MRSNMersana Therapeutics, Inc. | COM | 418,562 | $1.38M | 0.3% | +407,941+3,840.9% | Added | History |
| ELEVElevation Acquisition Group Inc. | COM | 900,000 | $1.37M | 0.3% | +900,000 | New | History |
| DYNDyne Therapeutics, Inc. | COM | 119,918 | $1.35M | 0.3% | −99,398−45.3% | Reduced | History |
| INBXInhibrx Biosciences, Inc. | COM | 50,000 | $1.30M | 0.3% | +50,000 | New | History |
| MDWDMediWound Ltd. | SHS NEW | 111,127 | $1.18M | 0.3% | 00.0% | Unchanged | History |
| PMVPPMV Pharmaceuticals, Inc. | COM | 187,800 | $1.18M | 0.3% | 00.0% | Unchanged | History |
| Immatics N.V.N44445117 | *W EXP 07/01/202 | 100,000 | $342.0K | 0.1% | 00.0% | Unchanged | – |
| INFIInfinity Pharmaceuticals, Inc. | COM | 1,476,000 | $310.7K | 0.1% | 00.0% | Unchanged | History |
| Bio Green Med Solution, Inc.23254L603 | COM | 250,000 | $147.3K | <0.1% | 00.0% | Unchanged | – |
| ARBEArbe Robotics Ltd. | COM | 43,165 | $124.7K | <0.1% | 00.0% | Unchanged | History |
Options (11)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | – | $61.3M |
| Invesco QQQ Trust Series I46090E103 | ETF | $46.5M | – |
| AMDAdvanced Micro Devices Inc | Stock | – | $13.7M |
| TSEMTower Semiconductor Ltd | SHS NEW | $12.5M | – |
| SRPTSarepta Therapeutics, Inc. | COM | – | $8.97M |
| GNRCGenerac Holdings Inc. | Stock | – | $7.83M |
| MSFTMicrosoft Corp | Stock | – | $7.15M |
| ENPHEnphase Energy, Inc. | Stock | – | $6.70M |
| ARGXArgenx SE | SPONSORED ADR | $3.90M | – |
| NICENICE Ltd. | SPONSORED ADR | – | $3.10M |
| BBIOBridgeBio Pharma, Inc. | COM | – | $2.24M |
Sold out since Q1 2023 (17)
Positions held at the end of Q1 2023 that are gone from this filing.
| Security | Class | Shares in Q1 2023 | Value in Q1 2023 | % of portfolio in Q1 2023 | History |
|---|---|---|---|---|---|
| NTRNutrien Ltd. | COM | 145,466 | $10.7M | 2.3% | History |
| Invesco QQQ Trust Series I46090E103 | ETF | 26,353 | $8.46M | 1.8% | – |
| Bellus Health Inc New07987C204 | COM NEW | 799,860 | $5.76M | 1.2% | – |
| PERIPerion Network Ltd. | SHS NEW | 130,000 | $5.15M | 1.1% | History |
| KNSAKiniksa Pharmaceuticals International, plc | COM CL A | 450,283 | $4.85M | 1.0% | History |
| PCVXVaxcyte, Inc. | COM | 90,000 | $3.37M | 0.7% | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 109,336 | $2.63M | 0.6% | History |
| AMGNAmgen Inc | Stock | 10,000 | $2.42M | 0.5% | History |
| KDNYChinook Therapeutics, Inc. | COM | 92,200 | $2.13M | 0.5% | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 82,747 | $1.33M | 0.3% | History |
| KROSKeros Therapeutics, Inc. | COM | 30,119 | $1.29M | 0.3% | History |
| ANNXAnnexon, Inc. | COM | 250,000 | $962.5K | 0.2% | History |
| RETAReata Pharmaceuticals Inc | CL A | 7,689 | $699.1K | 0.2% | History |
| Fiverr Intl Ltd33835LAA3 | NOTE 11/0 | 250,000 | $208.2K | <0.1% | – |
| SYRESpyre Therapeutics, Inc. | COM | 646,478 | $187.5K | <0.1% | History |
| OTMOOtonomo Technologies Ltd. | ORDINARY SHARES | 391,863 | $186.4K | <0.1% | History |
| ONCROncorus, Inc. | COM | 540,258 | $185.9K | <0.1% | History |